| Přispěvatelé: | Reitsma, P.H., Bos, M.H.A., Versteeg, H.H., Meijer, A.B., Castoldi, E., Leiden University |
|---|---|
| Rok vydání: | 2021 |
| Předmět: | |
| Popis: | The venom of the Australian snake Pseudonaja textilis contains coagulation factors V (five) and X (ten) which have been adapted to derail the blood clotting system of its prey. Snake venom factor V is unique in that is constitutively active, unlike its human counterpart. The snake liver transcriptome was found to contain alternatively spliced factor V mRNA that encoded for either the activated protein or its quiescent form. A potential pre-mRNA splicing mechanism was uncovered that may yield the active protein. Snake venom factor V is also particularly stable due to several modifications to its molecular structure. These modifications have been investigated in detail by engineering chimeras of human and snake venom factor V. The snake venom factor X molecule was also investigated in more detail. It was discovered that this enzyme is insensitive to the action of certain anticoagulant drugs (Factor Xa inhibitors) due to a unique molecular modification. A Human factor X can be modified in similar fashion, so that it is no longer sensitive to the action of Factor Xa inhibitors. This finding could make an important contribution to acute care for patients who experience life-threatening bleeding after the use of FXa inhibitors. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|